Scientists determined the effect of α-mangostin (α-MG) treatment in mediating the process of renal interstitial fibrosis. They found that α-MG could alleviate tubule-interstitial damage and decrease fibrotic, and epithelial-mesenchymal transition protein expression in unilateral ureteral obstruction mice with chronic kidney disease.
[Biochemical Pharmacology]